Friday, 29 April 2016

Shilpa Medicare Ltd Walk In On 01/05/16 @ Ahmedabad

REFERENCE
Srinivasulu Tirumalasetty
Global pharma News

WALK IN DATE : 01/05/16

VENUE :
Hotel Comfort In president
Ahmedabad

COMPANY : Shilpa Medicare Ltd

JOB LOCATION : Hyderabad

DEVISON : Formulation

DEPARTMENTS: QA,QC,Microbiology,Engineering

For more details go through below poster

ABOUT :
Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. We initially started producing Trimethoprim IP/BP with in-house developed technology. During the first year of its operation, the Company had expanded the production facilities to manufacture Trimethoprim apart from selling on its own, for other reputed Companies like Eskayef Limited, Bombay Drugs and Pharmas Limited, Bombay Drug House Ltd., US Vitamins Ltd, Sandoz India Ltd etc. for their export commitments.
Near 1992, the Company had further enhanced its operations by inducting new production facilities for manufacture of Sodium Methoxide. The technology for the Sodium Methoxide was also developed in house. About the same time, the Company secured export business from Stellar Exports Limited, Glaxo Limited and Deepak Nitrite Limited for Trimethoprim. Since then Shilpa Medicare Limited has started exporting on its own. The Company thus started manufacturing for both export and domestic markets since 1992.
The Company then embarked upon an expansion project which involved the addition of one more bulk drugs to its existing product range viz; Norfloxcin and expansion of the production capacity of the existing products of the Company viz; Sodium Methoxide and Trimethoprim. The Company also developed a process for drug intermediate- 1-methyl amino-1-methylthio- 2-nitro ethane, used in the manufacture of Ranitidine, which is an anti-ulcer drug. In November 1993, Shilpa Medicare was converted into a Public Limited Company. The Company was listed on Bombay Stock Exchange on Jun 19, 1995 and National Stock Exchange (NSE) on Dec 03, 2009.Subsequently; Shilpa Medicare has gained World Health Organization-Good Manufacturing Practices (GMP) Certificate recognition. In our relentless efforts for growth-Shilpa Medicare successfully set up a 100% EOU project in FY10 incurring a capital expenditure of nearly Rs.1000 million.


Thank you for visiting my blog , Visit again for latest pharma updates.

1 comment:

  1. Excellent .. Amazing .. I’ll bookmark your blog and take the feeds also…I’m happy to find so many useful info here in the post, we need work out more techniques in this regard, thanks for sharing.
    restasis from india

    ReplyDelete